As schemed in Figure 6, GCS up-regulates expression of GCS-responsive genes and modulates cell signaling pathways to enhance drug efflux, decrease apoptosis, and enrich cancer stem cells and even immune evasion, thus advancing drug resistance and tumor metastasis in tumor progression. This evidence concerns the gene UGCG and cancer.